RecruitingPhase 2NCT07303777

Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate the Efficacy, Safety, and Population Pharmacokinetics (PopPK) Profile of ABP-745 in Patients With Atherosclerosis

Sponsor

Atom Therapeutics Co., Ltd

Enrollment

200 participants

Start Date

Apr 23, 2026

Study Type

INTERVENTIONAL

Conditions

ASCVD Atherosclerosis Cardiovascular Disease ASCVD Management

Summary

This is a multicenter, randomized, double-blind, placebo parallel controlled study to evaluate the preliminary efficacy, safety, and PopPK profile of ABP-745 in patients with ASCVD. Efficacy of ABP-745 in reducing atherosclerotic plaque compared with placebo will be evaluated in participants with ASCVD. The primary efficacy measurement will be assessed at 52W of treatment.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called ABP-745 Dose A, a drug called ABP-745 Dose B, and others for people with ascvd, ascvd management, and other related conditions. The study is currently recruiting participants at 33 locations. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGABP-745 Dose A

ABP-745 Dose A - tablets (PO), low dose , QD

DRUGPlacebo

ABP-745 placebo - tablets (PO), non-active,QD

DRUGABP-745 Dose B

ABP-745 Dose B - tablets (PO), Midum dose, QD

DRUGABP-745 Dose C

ABP-745 Dose C - tablets (PO), High dose, QD

Locations(33)

Cardiovascular Research Foundation of Southern California

Beverly Hills, California, United States

Cardiovascular Institute of San Diego INC

San Diego, California, United States

The Lundquist Institute

Torrance, California, United States

Washington University School of Medicine, St.louis

St Louis, Missouri, United States

NovaTrails

Newcastle, New South Wales, Australia

University of the Sunshine Coast Clinical Trials Unit - Morayfield

Morayfield, Queensland, Australia

Core Research Group Pty Ltd

Brisbane, Australia

UniSC Clinical Trials (Brisbane)

Brisbane, Australia

Cognivus

Wahroonga, Australia

Beijing Friendship Hospital, Capital Medical University

Beijing, China

Peking Union Medical College Hospital

Beijing, China

Peking University First Hospital

Beijing, China

Xuanwu Hospital Capital Medical University

Beijing, China

Dalian Second Hospital

Dalian, China

Guangdong Province Hospital

Guangzhou, China

Sir Run Run Shaw Hospital of Zhejiang University School of Medicine

Hangzhou, China

The First Affiliated Hospital of Zhejiang University school of medicine

Hangzhou, China

Zhejiang Provincial People's Hospital

Hangzhou, China

Jinan Central Hospital

Jinan, China

Jiangsu Province Hospital

Nanjing, China

Nanjing Drum Tower Hospital

Nanjing, China

Huashan Hospital Fudan University

Shanghai, China

Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Shanghai, China

Shanghai General Hospital

Shanghai, China

The Zhongshan Hospital Affiliated to Fudan University

Shanghai, China

The First Affiliated Hospital of Soochow University

Suzhou, China

Tianjin General Hospital

Tianjin, China

Renmin Hospital of Wuhan University

Wuhan, China

Wuxi People's Hospital

Wuxi, China

Shaanxi Provincial People's Hospital

Xi'an, China

The First Affiliated Hospital of Xian Jiaotong University

Xi'an, China

The Second Affiliated Hospital of Xi'an Jiaotong University

Xi'an, China

The Affiliated Hospital of Xuzhou Medical College

Xuzhou, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07303777

Related Trials

Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

NCT076650341 location

A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

NCT07241390568 locations

Multimodal Biomarkers in Coronary Artery Disease Pathogenesis: The Oxford Acute Myocardial Infarction Study (OXAMI Study)

NCT07772570

Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors

NCT056113071 location

Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?

NCT064710361 location